
- Volume 0 0
More Than Half Test Positive for Common Allergens
The results of a skin test foundthat 54% of the US population aged6 to 59 had a positive reaction to atleast 1 of 10 common allergens. Apositive result was determined bythe size of a welt on the skin, comparedwith a prick from a negativecontrol. Therefore, the positivegroup was more likely to have asthma,hay fever, or eczema. The findingswere based on the ThirdNational Health and Nutrition ExaminationSurvey that included skintests on 10,500 individuals between1988 and 1994.
The government study indicatedthat 25% of the population testedpositive for allergies to dust mites,perennial rye, ragweed, and cockroaches.Of the participants, only9% had a peanut allergy. The researchersfrom the National Instituteof Environmental Health Sciencesand the National Institute of Allergyand Infectious Diseases also comparedskin-test responses betweenthe current survey and similar testsconducted in 1976-1980. The comparisonshowed that prevalence ofsensitivity to the 6 allergens thatwere tested in both surveys was 2 to5.5 times higher in the later round.The first survey tested 8 allergens.(The findings were reported in theJournal of Allergy and ClinicalImmunology, August 2005.)
Articles in this issue
about 20 years ago
A Pharmacist's Guide to OTC Therapy: Ocular Care Productsabout 20 years ago
Dangerous Liaisons: Schizophrenia and Diabetesabout 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplementsabout 20 years ago
Tarceva Extends Lung Cancer Survivalabout 20 years ago
Inhaled Morphine Aids Cancer-related Dyspneaabout 20 years ago
Diuretic Best BP Therapy for African Americansabout 20 years ago
A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Productsabout 20 years ago
New Drug Blocks Out AIDS Virusabout 20 years ago
Viagra Ingredient Has Another Useabout 20 years ago
GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIANewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































